<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03060707</url>
  </required_header>
  <id_info>
    <org_study_id>H1612-115-817</org_study_id>
    <nct_id>NCT03060707</nct_id>
  </id_info>
  <brief_title>Continuous Infusion Versus Intermittent Bolus Injection of Rocuronium</brief_title>
  <acronym>RCVB</acronym>
  <official_title>Comparison of Hourly Rocuronium Consumption Using Continuous Infusion Versus Intermittent Bolus Injection: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research is to find out whether continuous infusion of rocuronium requires more or less
      amount of rocuronium, per kilogram and per hour, than bolus administered rocuronium during
      noncardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      comparing the total dose of rocuronium between continuous infusion and intermittent injection
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rocuronium dose per kilogram per hour</measure>
    <time_frame>end of the surgery</time_frame>
    <description>Total dose of rocuronium injected during surgery, divided by patient body weight and anesthesia time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Desaturation event</measure>
    <time_frame>Right after the patient is transferred to the ward, from PACU (1 day)</time_frame>
    <description>Whether the participant's peripheral oxygen saturation (SpO2) decreased less than 93%, in postanesthesia care unit (PACU).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical rating scale</measure>
    <time_frame>end of the surgery</time_frame>
    <description>Numerical scale describing how easy it is for surgeon to access surgical field, ranging from1 to 5</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Muscle Relaxation</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Continuous infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The group of participants who are designated to receive continuously infused rocuronium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bolus administration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group of participants who are designated to receive bolus administered rocuronium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium Bromide</intervention_name>
    <description>Continuously infuse, or bolus administer rocuronium.</description>
    <arm_group_label>Continuous infusion</arm_group_label>
    <arm_group_label>Bolus administration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients aged between 2 and 12, undergoing elective noncardiac surgery which
             requires general anesthesia but does not require intense block, and estimated time of
             surgery is between 2 and 5 hours

        Exclusion Criteria:

          -  ASA class 3-6

          -  BMI &gt;= 30

          -  Previous history of hepatic failure, renal failure or neuromuscular disease

          -  Patients taking medicine which interacts with rocuronium bromide, before or during
             surgery: aminoglycosides, lincosamides, acylamino-penicillin antibiotics,
             tetracyclines, metronidazole (high dose), diuretics, MAO inhibitors, calcium channel
             blockers, corticosteroids, phenytoin, carbamazepine, or norepinephrine

          -  Previous history of allergic reaction (including anaphylactic reaction) and/or
             malignant hyperthermia during general anesthesia

          -  Patients taking medicines which contains magnesium
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hee-Soo Kim, Prof.</last_name>
    <phone>+82 02-2072-3659</phone>
    <email>dami0605@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>SNUH</name>
      <address>
        <city>Seoul</city>
        <state>Jongro Gu</state>
        <zip>15710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Soo Kim, M.D., PhD</last_name>
      <phone>82-2-2072-3659</phone>
      <email>dami0605@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2017</study_first_submitted>
  <study_first_submitted_qc>February 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Soo Kim</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Bromides</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

